Not finding it? Sign in to also search OpenAlex live.
-
Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review
Manuel Stöth, Till Jasper Meyer, Thomas Eckhard Gehrke, Rudolf Hagen, Matthias Scheich, Stephan Hackenberg, +1 more
6citations -
Switching PD‐1 to BRAF + MEK inhibition improves recurrence‐free survival in patients receiving a second course of adjuvant melanoma therapy2025 Journal of the European Academy of Dermatology and Venereology article Medicine Cutaneous Melanoma Detection and Management Open access
Katharina Schumann, Kai Christian Klespe, Cornelia Mauch, Carmen Loquai, Ulrike Schultheis, Sevil Börger, +20 more
1citations -
Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with NUP214 rearrangements2020 Oncotarget article Biochemistry, Genetics and Molecular Biology Nuclear Structure and Function Open access
Adélia Mendes, Ramona Jühlen, Valérie Martinelli, Birthe Fahrenkrog
15citations -
Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with NUP214 rearrangements2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Nuclear Structure and Function Open access
Adélia Mendes, Ramona Jühlen, Valérie Martinelli, Birthe Fahrenkrog
1citations -
Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center study2023 European Archives of Oto-Rhino-Laryngology article Medicine Cutaneous Melanoma Detection and Management Open access
Agmal Scherzad, Manuel Stöth, Till Jasper Meyer, Lukas Haug, Thomas Eckhard Gehrke, Bastian Schilling, +5 more
12citations -
Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro2020 Therapeutic Advances in Medical Oncology article Medicine Polyomavirus and related diseases Open access
Emil Chteinberg, Suzan Wetzels, Lieve Temmerman, Joost van den Oord, Erik A.L. Biessen, Anna Kordelia Kurz, +4 more
13citations -
Computational modeling analysis of the biotechnological exploitability of cyanobacteria photosynthesis considering the spectral light distribution0citations
-
469 Survey on the usage of PARP-inhibitor therapy in Germany – a national NOGGO/JAGO-AGO intergroup study2021 International Journal of Gynecological Cancer article Medicine PARP inhibition in cancer therapy Open access
Bich Doan Nguyen-Sträuli, P Meyer-Wilmes, Joanna Baum, A Kreklau, Christina Buschmann, S Boz, +6 more
0citations -
Percutaneous Transluminal Angioplasty and Stenting for Symptomatic Intracranial Stenosis After SAMMPRIS: Patient Selection and Clinical Outcomes2026 Journal of Clinical Medicine article Medicine Cerebrovascular and Carotid Artery Diseases Open access
Leonhard Mann, Patrick Felix Samp, Jan Hendrik Schäefer, Elke Hattingen, Joachim Berkefeld, Dimah Hasan, +1 more
0citations -
Engineering of Sono-Activatable Immunogels for Immunometabolism Disorder Normalization Therapy of Breast Cancer2025 Journal of the American Chemical Society article Engineering Nanoplatforms for cancer theranostics
Jiaxing Pan, Junjue Wang, Huijuan Zhang, Wenfang Yang, Fangmin Chen, Bowen Yin, +7 more
35citations